Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Insider: Tela Bio, Airbnb among week's notable insider trades » 15:10
06/13/22
06/13
15:10
06/13/22
15:10
TELA

Tela Bio

$5.85 /

+0.095 (+1.65%)

, UAL

United Airlines

$37.20 /

-3.95 (-9.60%)

, CHWY

Chewy

$27.55 /

-1.105 (-3.86%)

, SOFI

SoFi Technologies

$5.47 /

-0.465 (-7.83%)

, A

Agilent

$116.84 /

-4.12 (-3.41%)

, AEP

American Electric

$93.80 /

-4.5 (-4.58%)

, APTV

Aptiv

$95.12 /

-6.275 (-6.19%)

, ABNB

Airbnb

$99.73 /

-9.2 (-8.45%)

Welcome to "Fly Insider,"…

ShowHide Related Items >><<
UAL United Airlines
$37.20 /

-3.95 (-9.60%)

TELA Tela Bio
$5.85 /

+0.095 (+1.65%)

SOFI SoFi Technologies
$5.47 /

-0.465 (-7.83%)

CHWY Chewy
$27.55 /

-1.105 (-3.86%)

APTV Aptiv
$95.12 /

-6.275 (-6.19%)

AEP American Electric
$93.80 /

-4.5 (-4.58%)

ABNB Airbnb
$99.73 /

-9.2 (-8.45%)

A Agilent
$116.84 /

-4.12 (-3.41%)

TELA Tela Bio
$5.85 /

+0.095 (+1.65%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
UAL United Airlines
$37.20 /

-3.95 (-9.60%)

05/06/22 Wolfe Research
United Airlines upgraded to Peer Perform from Underperform at Wolfe Research
04/25/22 Citi
United Airlines price target raised to $71 from $58 at Citi
04/22/22 MKM Partners
United Airlines price target raised to $59 from $53 at MKM Partners
04/22/22 Morgan Stanley
United Airlines price target raised to $67 from $62 at Morgan Stanley
CHWY Chewy
$27.55 /

-1.105 (-3.86%)

06/03/22 Wells Fargo
Chewy price target lowered to $55 from $65 at Wells Fargo
06/02/22 Citi
Chewy price target lowered to $29 from $45 at Citi
06/02/22 Baird
Chewy price target lowered to $45 from $60 at Baird
06/02/22 RBC Capital
Chewy price target lowered to $59 from $73 at RBC Capital
SOFI SoFi Technologies
$5.47 /

-0.465 (-7.83%)

05/17/22 Mizuho
SoFi Technologies price target lowered to $9 from $14 at Mizuho
05/16/22 Piper Sandler
Piper upgrades SoFi to buy ahead of 'significant' earnings ramp
05/16/22 Piper Sandler
SoFi Technologies upgraded to Overweight from Neutral at Piper Sandler
05/12/22 Citi
SoFi Technologies price target lowered to $11 from $17 at Citi
A Agilent
$116.84 /

-4.12 (-3.41%)

06/03/22 Cowen
Agilent premium valuation remains warranted, says Cowen
06/02/22 KeyBanc
Agilent price target lowered to $155 from $195 at KeyBanc
05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
AEP American Electric
$93.80 /

-4.5 (-4.58%)

04/25/22 Credit Suisse
American Electric initiated with an Outperform at Credit Suisse
03/29/22 Mizuho
American Electric price target raised to $104 from $94 at Mizuho
03/14/22 Seaport Global
American Electric downgraded to Neutral after strategic shift at Seaport Global
03/14/22 Seaport Global
American Electric downgraded to Neutral from Buy at Seaport Global
APTV Aptiv
$95.12 /

-6.275 (-6.19%)

06/01/22 Goldman Sachs
Aptiv price target lowered to $135 from $150 at Goldman Sachs
06/01/22 Morgan Stanley
Aptiv price target lowered to $155 from $170 at Morgan Stanley
05/09/22 Deutsche Bank
Aptiv price target lowered to $137 from $140 at Deutsche Bank
05/06/22 Cowen
Aptiv price target lowered to $144 from $150 at Cowen
ABNB Airbnb
$99.73 /

-9.2 (-8.45%)

06/09/22 Goldman Sachs
Airbnb price target lowered to $95 from $150 at Goldman Sachs
06/03/22 Truist
Airbnb price target lowered to $160 from $190 at Truist
05/12/22 Citi
Airbnb share 'dislocation' brings buying opportunity, says Citi
05/11/22 Truist
Airbnb's new features should contribute to bookings growth, says Truist
UAL United Airlines
$37.20 /

-3.95 (-9.60%)

TELA Tela Bio
$5.85 /

+0.095 (+1.65%)

SOFI SoFi Technologies
$5.47 /

-0.465 (-7.83%)

CHWY Chewy
$27.55 /

-1.105 (-3.86%)

APTV Aptiv
$95.12 /

-6.275 (-6.19%)

AEP American Electric
$93.80 /

-4.5 (-4.58%)

ABNB Airbnb
$99.73 /

-9.2 (-8.45%)

A Agilent
$116.84 /

-4.12 (-3.41%)

  • 16
    Nov
UAL United Airlines
$37.20 /

-3.95 (-9.60%)

SOFI SoFi Technologies
$5.47 /

-0.465 (-7.83%)

CHWY Chewy
$27.55 /

-1.105 (-3.86%)

APTV Aptiv
$95.12 /

-6.275 (-6.19%)

ABNB Airbnb
$99.73 /

-9.2 (-8.45%)

UAL United Airlines
$37.20 /

-3.95 (-9.60%)

TELA Tela Bio
$5.85 /

+0.095 (+1.65%)

SOFI SoFi Technologies
$5.47 /

-0.465 (-7.83%)

CHWY Chewy
$27.55 /

-1.105 (-3.86%)

APTV Aptiv
$95.12 /

-6.275 (-6.19%)

ABNB Airbnb
$99.73 /

-9.2 (-8.45%)

A Agilent
$116.84 /

-4.12 (-3.41%)

UAL United Airlines
$37.20 /

-3.95 (-9.60%)

SOFI SoFi Technologies
$5.47 /

-0.465 (-7.83%)

CHWY Chewy
$27.55 /

-1.105 (-3.86%)

ABNB Airbnb
$99.73 /

-9.2 (-8.45%)

A Agilent
$116.84 /

-4.12 (-3.41%)

Conference/Events
American Society of Clinical Oncology to hold annual meeting » 04:55
06/07/22
06/07
04:55
06/07/22
04:55
A

Agilent

$127.66 /

-0.79 (-0.62%)

, ALKS

Alkermes

$28.35 /

-0.935 (-3.19%)

, BDSX

Biodesix

$1.54 /

+0.085 (+5.84%)

, CSTL

Castle Biosciences

$21.53 /

+2.405 (+12.58%)

, ABBV

AbbVie

$146.65 /

-0.56 (-0.38%)

, ACET

Adicet Bio

$12.24 /

+0.74 (+6.43%)

, ACLX

Arcellx

$15.92 /

+3.295 (+26.10%)

, ADAP

Adaptimmune

$1.52 /

-0.145 (-8.73%)

, PFE

Pfizer

$53.23 /

+0.03 (+0.06%)

, PBYI

Puma Biotechnology

$2.39 /

+0.05 (+2.14%)

, ONCY

Oncolytics

$1.03 /

-0.075 (-6.79%)

, NVTA

Invitae

$2.93 /

-0.085 (-2.82%)

, NVS

Novartis

$88.68 /

-0.43 (-0.48%)

, NEO

NeoGenomics

$8.00 /

-0.075 (-0.93%)

, MTEM

Molecular Templates

/

+

, VBLT

VBL Therapeutics

$1.55 /

-0.07 (-4.32%)

, DSNKY

Daiichi Sankyo

$26.02 /

+1.02 (+4.08%)

, GLSI

Greenwich LifeSciences

$8.33 /

-0.675 (-7.50%)

, RTX

Raytheon Technologies

$97.25 /

+0.865 (+0.90%)

, SGEN

Seagen

$142.41 /

+2.5 (+1.79%)

, RHHBY

Roche

$41.23 /

-0.32 (-0.77%)

, EXEL

Exelixis

$18.80 /

-0.26 (-1.36%)

, FGEN

FibroGen

$9.52 /

-0.43 (-4.32%)

, CAH

Cardinal Health

$53.76 /

-0.075 (-0.14%)

, CBIO

Catalyst Biosciences

$1.15 /

-0.08 (-6.50%)

, ARVN

Arvinas

$42.76 /

-1.46 (-3.30%)

, AURA

Aura Biosciences

$17.44 /

-0.15 (-0.85%)

2022 ASCO Annual Meeting…

2022 ASCO Annual Meeting to be held in Chicago on June 3-7.

ShowHide Related Items >><<
VBLT VBL Therapeutics
$1.55 /

-0.07 (-4.32%)

SGEN Seagen
$142.41 /

+2.5 (+1.79%)

RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

RHHBY Roche
$41.23 /

-0.32 (-0.77%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

PBYI Puma Biotechnology
$2.39 /

+0.05 (+2.14%)

ONCY Oncolytics
$1.03 /

-0.075 (-6.79%)

NVTA Invitae
$2.93 /

-0.085 (-2.82%)

NVS Novartis
$88.68 /

-0.43 (-0.48%)

NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

MTEM Molecular Templates
/

+

GLSI Greenwich LifeSciences
$8.33 /

-0.675 (-7.50%)

FGEN FibroGen
$9.52 /

-0.43 (-4.32%)

EXEL Exelixis
$18.80 /

-0.26 (-1.36%)

DSNKY Daiichi Sankyo
$26.02 /

+1.02 (+4.08%)

CSTL Castle Biosciences
$21.53 /

+2.405 (+12.58%)

CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

AURA Aura Biosciences
$17.44 /

-0.15 (-0.85%)

ARVN Arvinas
$42.76 /

-1.46 (-3.30%)

ALKS Alkermes
$28.35 /

-0.935 (-3.19%)

ADAP Adaptimmune
$1.52 /

-0.145 (-8.73%)

ACLX Arcellx
$15.92 /

+3.295 (+26.10%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

A Agilent
$127.66 /

-0.79 (-0.62%)

A Agilent
$127.66 /

-0.79 (-0.62%)

06/03/22 Cowen
Agilent premium valuation remains warranted, says Cowen
06/02/22 KeyBanc
Agilent price target lowered to $155 from $195 at KeyBanc
05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
ALKS Alkermes
$28.35 /

-0.935 (-3.19%)

04/28/22 Mizuho
Alkermes price target raised to $36 from $35 at Mizuho
04/28/22 H.C. Wainwright
Alkermes price target raised to $32 from $30 at H.C. Wainwright
04/27/22 Stifel
Alkermes price target raised to $27 from $24 at Stifel
04/20/22 Goldman Sachs
Alkermes initiated with a Buy at Goldman Sachs
BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
CSTL Castle Biosciences
$21.53 /

+2.405 (+12.58%)

05/19/22 Baird
Baird says final LCD for test 'incrementally positive' for Castle Biosciences
05/10/22 Canaccord
Castle Biosciences price target lowered to $65 from $80 at Canaccord
05/10/22 Baird
Castle Biosciences price target lowered to $44 from $50 at Baird
05/09/22 BTIG
Castle Biosciences transferred with a Buy at BTIG
ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

05/23/22 SVB Securities
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

03/30/22 SMBC Nikko
Adicet Bio initiated with an Outperform at SMBC Nikko
03/17/22 JMP Securities
Adicet Bio price target lowered to $21 from $30 at JMP Securities
03/08/22 Truist
Adicet Bio initiated with a Buy at Truist
03/04/22 Jefferies
Adicet Bio initiated with a Buy at Jefferies
ACLX Arcellx
$15.92 /

+3.295 (+26.10%)

03/02/22 Barclays
Arcellx initiated with an Overweight at Barclays
03/01/22 SVB Securities
Arcellx initiated with an Outperform at SVB Leerink
03/01/22 BofA
Arcellx initiated with a Buy at BofA
03/01/22 BofA
Arcellx initiated with a Buy at BofA
ADAP Adaptimmune
$1.52 /

-0.145 (-8.73%)

11/11/21 Roth Capital
Roth says Adaptimmune synovial sarcoma trial hitting goal appears 'a certainty'
PFE Pfizer
$53.23 /

+0.03 (+0.06%)

06/03/22 Oppenheimer
Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
05/31/22 Evercore ISI
Enanta upgraded to In Line from Underperform at Evercore ISI
05/25/22 Piper Sandler
Piper Sandler says Ventyx Biosciences' VTX002 could produce superior efficacy
05/23/22 Piper Sandler
Biohaven price target lowered to $149 from $170 at Piper Sandler
PBYI Puma Biotechnology
$2.39 /

+0.05 (+2.14%)

05/06/22 H.C. Wainwright
Puma Biotechnology price target lowered to $12 from $14 at H.C. Wainwright
09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Citi
Puma Biotechnology upgraded to Buy after 40% selloff at Citi
09/27/21 Citi
Puma Biotechnology upgraded to Buy from Neutral at Citi
ONCY Oncolytics
$1.03 /

-0.075 (-6.79%)

01/27/22 Canaccord
Oncolytics price target lowered to $6 from $7 at Canaccord
NVTA Invitae
$2.93 /

-0.085 (-2.82%)

06/02/22 Piper Sandler
Invitae initiated with an Underweight at Piper Sandler
05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
11/09/21 Wells Fargo
Invitae price target lowered to $25 from $35 at Wells Fargo
NVS Novartis
$88.68 /

-0.43 (-0.48%)

05/13/22 Piper Sandler
Point Biopharma price target lowered to $14 from $17 at Piper Sandler
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
05/09/22 Wolfe Research
Novartis downgraded to Peer Perform from Outperform at Wolfe Research
NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

06/02/22 Piper Sandler
NeoGenomics initiated with an Overweight at Piper Sandler
03/29/22 Cowen
NeoGenomics price target lowered to $24 from $42 at Cowen
03/29/22 BTIG
NeoGenomics price target lowered to $28 from $35 at BTIG
03/29/22 SVB Securities
NeoGenomics price target lowered to $20 from $45 at SVB Leerink
MTEM Molecular Templates
/

+

05/27/22 BofA
Molecular Templates downgraded to Underperform from Buy at BofA
05/13/22 Stifel
Molecular Templates price target lowered to $9 from $11 at Stifel
03/30/22 Barclays
Molecular Templates price target lowered to $4.50 from $8 at Barclays
VBLT VBL Therapeutics
$1.55 /

-0.07 (-4.32%)

04/28/22 Chardan
VBL Therapeutics initiated with a Buy at Chardan
08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
DSNKY Daiichi Sankyo
$26.02 /

+1.02 (+4.08%)

10/27/21 SVB Securities
Seagen price target raised to $200 from $190 at SVB Leerink
GLSI Greenwich LifeSciences
$8.33 /

-0.675 (-7.50%)

09/01/21 H.C. Wainwright
Greenwich LifeSciences initiated with a Buy at H.C. Wainwright
RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
04/08/22 RBC Capital
Raytheon Technologies initiated with an Outperform at RBC Capital
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
SGEN Seagen
$142.41 /

+2.5 (+1.79%)

04/08/22 Roth Capital
Bicycle reported 'very strong' side-effect profile, says Roth Capital
04/08/22 Cantor Fitzgerald
Bicycle Therapeutics' BT8009 abstract 'very positive,' says Cantor Fitzgerald
02/24/22 Piper Sandler
Seagen's tisotumab vedotin shows 'modest signal of activity,' says Piper Sandler
02/16/22 JMP Securities
Seagen price target lowered to $142 from $201 at JMP Securities
RHHBY Roche
$41.23 /

-0.32 (-0.77%)

06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
05/19/22 Credit Suisse
Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse
05/12/22 Morgan Stanley
Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley
EXEL Exelixis
$18.80 /

-0.26 (-1.36%)

05/19/22 Piper Sandler
Exelixis sold off on Cabometyx patent trial comments, says Piper Sandler
05/19/22 Truist
Exelixis should be bought on dip caused by '776 patent worries, says Truist
05/12/22 Jefferies
Exelixis could approach $26-$28 if it settles or wins MSN trial, says Jefferies
03/14/22 Piper Sandler
Exelixis price target lowered to $30 from $34 at Piper Sandler
FGEN FibroGen
$9.52 /

-0.43 (-4.32%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Goldman Sachs
FibroGen downgraded to Sell from Neutral at Goldman Sachs
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

05/26/22 Barclays
Cardinal Health downgraded to Equal Weight from Overweight at Barclays
05/18/22 Evercore ISI
Evercore upgrades Cardinal Health to Outperform on undervalued Medical segment
05/18/22 Evercore ISI
Cardinal Health upgraded to Outperform from In Line at Evercore ISI
04/12/22 Morgan Stanley
McKesson price target raised to $370 from $292 at Morgan Stanley
CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

05/23/22 Piper Sandler
Piper Sandler remains bullish on Catalyst after sale of complement portfolio
03/31/22 Piper Sandler
Piper says 'stick it out' with Catalyst Biosciences exploring options
11/12/21 JonesTrading
Catalyst Biosciences downgraded to Hold from Buy at JonesTrading
11/12/21 Piper Sandler
Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler
ARVN Arvinas
$42.76 /

-1.46 (-3.30%)

05/23/22 Piper Sandler
Arvinas price target lowered to $76 from $116 at Piper Sandler
05/09/22 Wedbush
Wedbush downgrades Arvinas to Neutral, cuts price target to $43
05/09/22 Wedbush
Arvinas downgraded to Neutral from Outperform at Wedbush
05/06/22 Cantor Fitzgerald
Arvinas assumed with an Overweight at Cantor Fitzgerald
AURA Aura Biosciences
$17.44 /

-0.15 (-0.85%)

11/23/21 SVB Securities
Aura Biosciences initiated with an Outperform at SVB Leerink
11/23/21 BTIG
Aura Biosciences initiated with a Buy at BTIG
11/23/21 Evercore ISI
Evercore starts Aura Biosciences at Outperform with $35 price target
11/23/21 Cowen
Aura Biosciences initiated with an Outperform at Cowen
VBLT VBL Therapeutics
$1.55 /

-0.07 (-4.32%)

SGEN Seagen
$142.41 /

+2.5 (+1.79%)

RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

RHHBY Roche
$41.23 /

-0.32 (-0.77%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

PBYI Puma Biotechnology
$2.39 /

+0.05 (+2.14%)

ONCY Oncolytics
$1.03 /

-0.075 (-6.79%)

NVTA Invitae
$2.93 /

-0.085 (-2.82%)

NVS Novartis
$88.68 /

-0.43 (-0.48%)

NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

MTEM Molecular Templates
/

+

FGEN FibroGen
$9.52 /

-0.43 (-4.32%)

EXEL Exelixis
$18.80 /

-0.26 (-1.36%)

CSTL Castle Biosciences
$21.53 /

+2.405 (+12.58%)

CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

AURA Aura Biosciences
$17.44 /

-0.15 (-0.85%)

ARVN Arvinas
$42.76 /

-1.46 (-3.30%)

ALKS Alkermes
$28.35 /

-0.935 (-3.19%)

ADAP Adaptimmune
$1.52 /

-0.145 (-8.73%)

ACLX Arcellx
$15.92 /

+3.295 (+26.10%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

A Agilent
$127.66 /

-0.79 (-0.62%)

  • 04
    Feb
  • 08
    Dec
  • 29
    Oct
RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

RHHBY Roche
$41.23 /

-0.32 (-0.77%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

NVS Novartis
$88.68 /

-0.43 (-0.48%)

CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

SGEN Seagen
$142.41 /

+2.5 (+1.79%)

RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

RHHBY Roche
$41.23 /

-0.32 (-0.77%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

PBYI Puma Biotechnology
$2.39 /

+0.05 (+2.14%)

NVTA Invitae
$2.93 /

-0.085 (-2.82%)

NVS Novartis
$88.68 /

-0.43 (-0.48%)

NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

EXEL Exelixis
$18.80 /

-0.26 (-1.36%)

CSTL Castle Biosciences
$21.53 /

+2.405 (+12.58%)

CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

CAH Cardinal Health
$53.76 /

-0.075 (-0.14%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

ARVN Arvinas
$42.76 /

-1.46 (-3.30%)

ALKS Alkermes
$28.35 /

-0.935 (-3.19%)

ADAP Adaptimmune
$1.52 /

-0.145 (-8.73%)

ACLX Arcellx
$15.92 /

+3.295 (+26.10%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

A Agilent
$127.66 /

-0.79 (-0.62%)

RTX Raytheon Technologies
$97.25 /

+0.865 (+0.90%)

PFE Pfizer
$53.23 /

+0.03 (+0.06%)

NVTA Invitae
$2.93 /

-0.085 (-2.82%)

NEO NeoGenomics
$8.00 /

-0.075 (-0.93%)

CBIO Catalyst Biosciences
$1.15 /

-0.08 (-6.50%)

BDSX Biodesix
$1.54 /

+0.085 (+5.84%)

ABBV AbbVie
$146.65 /

-0.56 (-0.38%)

A Agilent
$127.66 /

-0.79 (-0.62%)

Conference/Events
American Society of Clinical Oncology to hold annual meeting » 10:01
06/06/22
06/06
10:01
06/06/22
10:01
A

Agilent

$129.14 /

+0.69 (+0.54%)

, ALKS

Alkermes

$29.06 /

-0.225 (-0.77%)

, BDSX

Biodesix

$1.45 /

-0.005 (-0.34%)

, CSTL

Castle Biosciences

$20.66 /

+1.535 (+8.03%)

, ABBV

AbbVie

$146.29 /

-0.92 (-0.62%)

, ACET

Adicet Bio

$11.21 /

-0.29 (-2.52%)

, ACLX

Arcellx

$13.44 /

+0.815 (+6.46%)

, ADAP

Adaptimmune

$1.63 /

-0.03 (-1.81%)

, PFE

Pfizer

$53.19 /

-0.01 (-0.02%)

, PBYI

Puma Biotechnology

$2.37 /

+0.025 (+1.07%)

, ONCY

Oncolytics

$1.08 /

-0.025 (-2.26%)

, NVTA

Invitae

$2.94 /

-0.075 (-2.49%)

, NVS

Novartis

$89.27 /

+0.16 (+0.18%)

, NEO

NeoGenomics

$8.11 /

+0.04 (+0.50%)

, MTEM

Molecular Templates

$1.03 /

+0.0523 (+5.35%)

, VBLT

VBL Therapeutics

$1.62 /

+ (+0.00%)

, DSNKY

Daiichi Sankyo

$25.00 /

-0.4 (-1.57%)

, GLSI

Greenwich LifeSciences

$8.89 /

-0.11 (-1.22%)

, RTX

Raytheon Technologies

$96.73 /

+0.345 (+0.36%)

, SGEN

Seagen

$143.37 /

+3.46 (+2.47%)

, RHHBY

Roche

$41.55 /

-0.7 (-1.66%)

, EXEL

Exelixis

$18.95 /

-0.105 (-0.55%)

, FGEN

FibroGen

$9.86 /

-0.09 (-0.90%)

, CAH

Cardinal Health

$53.94 /

+0.1 (+0.19%)

, CBIO

Catalyst Biosciences

$1.34 /

+0.11 (+8.94%)

, ARVN

Arvinas

$45.33 /

+1.11 (+2.51%)

, AURA

Aura Biosciences

$17.57 /

-0.02 (-0.11%)

2022 ASCO Annual Meeting…

2022 ASCO Annual Meeting to be held in Chicago on June 3-7.

ShowHide Related Items >><<
VBLT VBL Therapeutics
$1.62 /

+ (+0.00%)

SGEN Seagen
$143.37 /

+3.46 (+2.47%)

RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

RHHBY Roche
$41.55 /

-0.7 (-1.66%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

PBYI Puma Biotechnology
$2.37 /

+0.025 (+1.07%)

ONCY Oncolytics
$1.08 /

-0.025 (-2.26%)

NVTA Invitae
$2.94 /

-0.075 (-2.49%)

NVS Novartis
$89.27 /

+0.16 (+0.18%)

NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

MTEM Molecular Templates
$1.03 /

+0.0523 (+5.35%)

GLSI Greenwich LifeSciences
$8.89 /

-0.11 (-1.22%)

FGEN FibroGen
$9.86 /

-0.09 (-0.90%)

EXEL Exelixis
$18.95 /

-0.105 (-0.55%)

DSNKY Daiichi Sankyo
$25.00 /

-0.4 (-1.57%)

CSTL Castle Biosciences
$20.66 /

+1.535 (+8.03%)

CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

AURA Aura Biosciences
$17.57 /

-0.02 (-0.11%)

ARVN Arvinas
$45.33 /

+1.11 (+2.51%)

ALKS Alkermes
$29.06 /

-0.225 (-0.77%)

ADAP Adaptimmune
$1.63 /

-0.03 (-1.81%)

ACLX Arcellx
$13.44 /

+0.815 (+6.46%)

ACET Adicet Bio
$11.21 /

-0.29 (-2.52%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

A Agilent
$129.14 /

+0.69 (+0.54%)

A Agilent
$129.14 /

+0.69 (+0.54%)

06/03/22 Cowen
Agilent premium valuation remains warranted, says Cowen
06/02/22 KeyBanc
Agilent price target lowered to $155 from $195 at KeyBanc
05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
ALKS Alkermes
$29.06 /

-0.225 (-0.77%)

04/28/22 Mizuho
Alkermes price target raised to $36 from $35 at Mizuho
04/28/22 H.C. Wainwright
Alkermes price target raised to $32 from $30 at H.C. Wainwright
04/27/22 Stifel
Alkermes price target raised to $27 from $24 at Stifel
04/20/22 Goldman Sachs
Alkermes initiated with a Buy at Goldman Sachs
BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
03/15/22 Canaccord
Biodesix price target lowered to $10 from $18 at Canaccord
CSTL Castle Biosciences
$20.66 /

+1.535 (+8.03%)

05/19/22 Baird
Baird says final LCD for test 'incrementally positive' for Castle Biosciences
05/10/22 Canaccord
Castle Biosciences price target lowered to $65 from $80 at Canaccord
05/10/22 Baird
Castle Biosciences price target lowered to $44 from $50 at Baird
05/09/22 BTIG
Castle Biosciences transferred with a Buy at BTIG
ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

05/23/22 SVB Securities
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
ACET Adicet Bio
$11.21 /

-0.29 (-2.52%)

03/30/22 SMBC Nikko
Adicet Bio initiated with an Outperform at SMBC Nikko
03/17/22 JMP Securities
Adicet Bio price target lowered to $21 from $30 at JMP Securities
03/08/22 Truist
Adicet Bio initiated with a Buy at Truist
03/04/22 Jefferies
Adicet Bio initiated with a Buy at Jefferies
ACLX Arcellx
$13.44 /

+0.815 (+6.46%)

03/02/22 Barclays
Arcellx initiated with an Overweight at Barclays
03/01/22 SVB Securities
Arcellx initiated with an Outperform at SVB Leerink
03/01/22 BofA
Arcellx initiated with a Buy at BofA
03/01/22 BofA
Arcellx initiated with a Buy at BofA
ADAP Adaptimmune
$1.63 /

-0.03 (-1.81%)

11/11/21 Roth Capital
Roth says Adaptimmune synovial sarcoma trial hitting goal appears 'a certainty'
PFE Pfizer
$53.19 /

-0.01 (-0.02%)

06/03/22 Oppenheimer
Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
05/31/22 Evercore ISI
Enanta upgraded to In Line from Underperform at Evercore ISI
05/25/22 Piper Sandler
Piper Sandler says Ventyx Biosciences' VTX002 could produce superior efficacy
05/23/22 Piper Sandler
Biohaven price target lowered to $149 from $170 at Piper Sandler
PBYI Puma Biotechnology
$2.37 /

+0.025 (+1.07%)

05/06/22 H.C. Wainwright
Puma Biotechnology price target lowered to $12 from $14 at H.C. Wainwright
09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Citi
Puma Biotechnology upgraded to Buy after 40% selloff at Citi
09/27/21 Citi
Puma Biotechnology upgraded to Buy from Neutral at Citi
ONCY Oncolytics
$1.08 /

-0.025 (-2.26%)

01/27/22 Canaccord
Oncolytics price target lowered to $6 from $7 at Canaccord
NVTA Invitae
$2.94 /

-0.075 (-2.49%)

06/02/22 Piper Sandler
Invitae initiated with an Underweight at Piper Sandler
05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
11/09/21 Wells Fargo
Invitae price target lowered to $25 from $35 at Wells Fargo
NVS Novartis
$89.27 /

+0.16 (+0.18%)

05/13/22 Piper Sandler
Point Biopharma price target lowered to $14 from $17 at Piper Sandler
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
05/09/22 Wolfe Research
Novartis downgraded to Peer Perform from Outperform at Wolfe Research
NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

06/02/22 Piper Sandler
NeoGenomics initiated with an Overweight at Piper Sandler
03/29/22 Cowen
NeoGenomics price target lowered to $24 from $42 at Cowen
03/29/22 BTIG
NeoGenomics price target lowered to $28 from $35 at BTIG
03/29/22 SVB Securities
NeoGenomics price target lowered to $20 from $45 at SVB Leerink
MTEM Molecular Templates
$1.03 /

+0.0523 (+5.35%)

05/27/22 BofA
Molecular Templates downgraded to Underperform from Buy at BofA
05/13/22 Stifel
Molecular Templates price target lowered to $9 from $11 at Stifel
03/30/22 Barclays
Molecular Templates price target lowered to $4.50 from $8 at Barclays
VBLT VBL Therapeutics
$1.62 /

+ (+0.00%)

04/28/22 Chardan
VBL Therapeutics initiated with a Buy at Chardan
08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
DSNKY Daiichi Sankyo
$25.00 /

-0.4 (-1.57%)

10/27/21 SVB Securities
Seagen price target raised to $200 from $190 at SVB Leerink
GLSI Greenwich LifeSciences
$8.89 /

-0.11 (-1.22%)

09/01/21 H.C. Wainwright
Greenwich LifeSciences initiated with a Buy at H.C. Wainwright
RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
04/08/22 RBC Capital
Raytheon Technologies initiated with an Outperform at RBC Capital
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
SGEN Seagen
$143.37 /

+3.46 (+2.47%)

04/08/22 Roth Capital
Bicycle reported 'very strong' side-effect profile, says Roth Capital
04/08/22 Cantor Fitzgerald
Bicycle Therapeutics' BT8009 abstract 'very positive,' says Cantor Fitzgerald
02/24/22 Piper Sandler
Seagen's tisotumab vedotin shows 'modest signal of activity,' says Piper Sandler
02/16/22 JMP Securities
Seagen price target lowered to $142 from $201 at JMP Securities
RHHBY Roche
$41.55 /

-0.7 (-1.66%)

06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
05/19/22 Credit Suisse
Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse
05/12/22 Morgan Stanley
Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley
EXEL Exelixis
$18.95 /

-0.105 (-0.55%)

05/19/22 Piper Sandler
Exelixis sold off on Cabometyx patent trial comments, says Piper Sandler
05/19/22 Truist
Exelixis should be bought on dip caused by '776 patent worries, says Truist
05/12/22 Jefferies
Exelixis could approach $26-$28 if it settles or wins MSN trial, says Jefferies
03/14/22 Piper Sandler
Exelixis price target lowered to $30 from $34 at Piper Sandler
FGEN FibroGen
$9.86 /

-0.09 (-0.90%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Goldman Sachs
FibroGen downgraded to Sell from Neutral at Goldman Sachs
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
08/20/21 Raymond James
FibroGen upgraded to Market Perform from Underperform at Raymond James
CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

05/26/22 Barclays
Cardinal Health downgraded to Equal Weight from Overweight at Barclays
05/18/22 Evercore ISI
Evercore upgrades Cardinal Health to Outperform on undervalued Medical segment
05/18/22 Evercore ISI
Cardinal Health upgraded to Outperform from In Line at Evercore ISI
04/12/22 Morgan Stanley
McKesson price target raised to $370 from $292 at Morgan Stanley
CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

05/23/22 Piper Sandler
Piper Sandler remains bullish on Catalyst after sale of complement portfolio
03/31/22 Piper Sandler
Piper says 'stick it out' with Catalyst Biosciences exploring options
11/12/21 JonesTrading
Catalyst Biosciences downgraded to Hold from Buy at JonesTrading
11/12/21 Piper Sandler
Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler
ARVN Arvinas
$45.33 /

+1.11 (+2.51%)

05/23/22 Piper Sandler
Arvinas price target lowered to $76 from $116 at Piper Sandler
05/09/22 Wedbush
Wedbush downgrades Arvinas to Neutral, cuts price target to $43
05/09/22 Wedbush
Arvinas downgraded to Neutral from Outperform at Wedbush
05/06/22 Cantor Fitzgerald
Arvinas assumed with an Overweight at Cantor Fitzgerald
AURA Aura Biosciences
$17.57 /

-0.02 (-0.11%)

11/23/21 SVB Securities
Aura Biosciences initiated with an Outperform at SVB Leerink
11/23/21 BTIG
Aura Biosciences initiated with a Buy at BTIG
11/23/21 Evercore ISI
Evercore starts Aura Biosciences at Outperform with $35 price target
11/23/21 Cowen
Aura Biosciences initiated with an Outperform at Cowen
VBLT VBL Therapeutics
$1.62 /

+ (+0.00%)

SGEN Seagen
$143.37 /

+3.46 (+2.47%)

RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

RHHBY Roche
$41.55 /

-0.7 (-1.66%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

PBYI Puma Biotechnology
$2.37 /

+0.025 (+1.07%)

ONCY Oncolytics
$1.08 /

-0.025 (-2.26%)

NVTA Invitae
$2.94 /

-0.075 (-2.49%)

NVS Novartis
$89.27 /

+0.16 (+0.18%)

NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

MTEM Molecular Templates
$1.03 /

+0.0523 (+5.35%)

FGEN FibroGen
$9.86 /

-0.09 (-0.90%)

EXEL Exelixis
$18.95 /

-0.105 (-0.55%)

CSTL Castle Biosciences
$20.66 /

+1.535 (+8.03%)

CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

AURA Aura Biosciences
$17.57 /

-0.02 (-0.11%)

ARVN Arvinas
$45.33 /

+1.11 (+2.51%)

ALKS Alkermes
$29.06 /

-0.225 (-0.77%)

ADAP Adaptimmune
$1.63 /

-0.03 (-1.81%)

ACLX Arcellx
$13.44 /

+0.815 (+6.46%)

ACET Adicet Bio
$11.21 /

-0.29 (-2.52%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

A Agilent
$129.14 /

+0.69 (+0.54%)

  • 04
    Feb
  • 08
    Dec
  • 29
    Oct
RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

RHHBY Roche
$41.55 /

-0.7 (-1.66%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

NVS Novartis
$89.27 /

+0.16 (+0.18%)

CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

SGEN Seagen
$143.37 /

+3.46 (+2.47%)

RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

RHHBY Roche
$41.55 /

-0.7 (-1.66%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

PBYI Puma Biotechnology
$2.37 /

+0.025 (+1.07%)

NVTA Invitae
$2.94 /

-0.075 (-2.49%)

NVS Novartis
$89.27 /

+0.16 (+0.18%)

NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

EXEL Exelixis
$18.95 /

-0.105 (-0.55%)

CSTL Castle Biosciences
$20.66 /

+1.535 (+8.03%)

CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

CAH Cardinal Health
$53.94 /

+0.1 (+0.19%)

BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

ARVN Arvinas
$45.33 /

+1.11 (+2.51%)

ALKS Alkermes
$29.06 /

-0.225 (-0.77%)

ADAP Adaptimmune
$1.63 /

-0.03 (-1.81%)

ACLX Arcellx
$13.44 /

+0.815 (+6.46%)

ACET Adicet Bio
$11.21 /

-0.29 (-2.52%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

A Agilent
$129.14 /

+0.69 (+0.54%)

RTX Raytheon Technologies
$96.73 /

+0.345 (+0.36%)

PFE Pfizer
$53.19 /

-0.01 (-0.02%)

NVTA Invitae
$2.94 /

-0.075 (-2.49%)

NEO NeoGenomics
$8.11 /

+0.04 (+0.50%)

CBIO Catalyst Biosciences
$1.34 /

+0.11 (+8.94%)

BDSX Biodesix
$1.45 /

-0.005 (-0.34%)

ABBV AbbVie
$146.29 /

-0.92 (-0.62%)

A Agilent
$129.14 /

+0.69 (+0.54%)

Recommendations
Agilent premium valuation remains warranted, says Cowen » 07:52
06/03/22
06/03
07:52
06/03/22
07:52
A

Agilent

$129.08 /

+5.91 (+4.80%)

Cowen analyst Dan Brennan…

Cowen analyst Dan Brennan believes the Agilent fundamentals are solid and the valuation premium is warranted and risks are manageable with the sector facing less pressure from recession versus. the 2008-2009 period. Brennan reiterated his Outperform rating and $159 price target on Agilent shares.

ShowHide Related Items >><<
A Agilent
$129.08 /

+5.91 (+4.80%)

A Agilent
$129.08 /

+5.91 (+4.80%)

06/02/22 KeyBanc
Agilent price target lowered to $155 from $195 at KeyBanc
05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
04/25/22 Wells Fargo
Agilent downgraded to Equal Weight from Overweight at Wells Fargo
A Agilent
$129.08 /

+5.91 (+4.80%)

A Agilent
$129.08 /

+5.91 (+4.80%)

A Agilent
$129.08 /

+5.91 (+4.80%)

Conference/Events
Agilent participates in a conference call with JPMorgan » 11:21
06/02/22
06/02
11:21
06/02/22
11:21
A

Agilent

$126.93 /

+3.76 (+3.05%)

Conference call with CEO…

Conference call with CEO McMullen to be held on June 2 at 1 pm hosted by JPMorgan. Webcast Link

ShowHide Related Items >><<
A Agilent
$126.93 /

+3.76 (+3.05%)

A Agilent
$126.93 /

+3.76 (+3.05%)

06/02/22 KeyBanc
Agilent price target lowered to $155 from $195 at KeyBanc
05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
04/25/22 Wells Fargo
Agilent downgraded to Equal Weight from Overweight at Wells Fargo
A Agilent
$126.93 /

+3.76 (+3.05%)

A Agilent
$126.93 /

+3.76 (+3.05%)

A Agilent
$126.93 /

+3.76 (+3.05%)

Recommendations
Agilent price target lowered to $155 from $195 at KeyBanc » 06:16
06/02/22
06/02
06:16
06/02/22
06:16
A

Agilent

$123.17 /

-4.49 (-3.52%)

KeyBanc analyst Paul…

KeyBanc analyst Paul Knight lowered the firm's price target on Agilent to $155 from $195 to reflect the contraction in peer-group multiples, while keeping an Overweight rating on the shares. Shanghai, the most significant market in China for Life Tool companies, has moved to reopen the metro area this week. The news comes as Agilent's valuation has retraced close to its five-year median EV/EBITDA, the analyst notes. The company, very close to the China market with a long operating history and the majority of its 33% Asian sales tied to the country, had previously indicated a back-half fiscal 2022 recovery. Knight sees higher visibility to his estimates and an attractive valuation for the shares.

ShowHide Related Items >><<
A Agilent
$123.17 /

-4.49 (-3.52%)

A Agilent
$123.17 /

-4.49 (-3.52%)

05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
04/25/22 Wells Fargo
Agilent downgraded to Equal Weight from Overweight at Wells Fargo
04/19/22 Truist
Moog Inc downgraded to Hold from Buy at Truist
A Agilent
$123.17 /

-4.49 (-3.52%)

A Agilent
$123.17 /

-4.49 (-3.52%)

A Agilent
$123.17 /

-4.49 (-3.52%)

Over a month ago
Hot Stocks
Agilent, APC announce liquid chromatography collaboration agreement » 08:06
05/27/22
05/27
08:06
05/27/22
08:06
A

Agilent

$123.84 /

+3.42 (+2.84%)

Agilent announced a…

Agilent announced a collaboration agreement with APC in which the companies commit to working towards combining their technologies to provide unique workflows to customers that support automated process analysis via liquid chromatography, or LC. Agilent has selected to partner with APC, a provider of small molecule and large molecule process design and process development solutions. Both APC and Agilent pursue similar goals, which are focused on helping customers in the biopharmaceutical and pharmaceutical industry to improve the human condition and to delivering life-changing drugs to market faster and more efficiently. The collaboration between the companies leverages their complementary strengths to develop specific workflows, which bridge the gap between the analytical and process solutions.

ShowHide Related Items >><<
A Agilent
$123.84 /

+3.42 (+2.84%)

A Agilent
$123.84 /

+3.42 (+2.84%)

05/25/22 Baird
Agilent price target raised to $161 from $155 at Baird
05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
04/25/22 Wells Fargo
Agilent downgraded to Equal Weight from Overweight at Wells Fargo
04/19/22 Truist
Moog Inc downgraded to Hold from Buy at Truist
A Agilent
$123.84 /

+3.42 (+2.84%)

A Agilent
$123.84 /

+3.42 (+2.84%)

A Agilent
$123.84 /

+3.42 (+2.84%)

Recommendations
Agilent price target raised to $161 from $155 at Baird » 06:17
05/25/22
05/25
06:17
05/25/22
06:17
A

Agilent

$124.71 /

-1.33 (-1.06%)

Baird analyst Catherine…

Baird analyst Catherine Ramsey Schulte raised the firm's price target on Agilent to $161 from $155 and keeps an Outperform rating on the shares. The analyst said management remains bullish on the outlook in China, as well as its portfolio positioning/mix in a potential broader recessionary scenario. She continues to like Agilent's organic setup here, with the potential for incremental capital deployment to drive upside.

ShowHide Related Items >><<
A Agilent
$124.71 /

-1.33 (-1.06%)

A Agilent
$124.71 /

-1.33 (-1.06%)

05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
04/25/22 Wells Fargo
Agilent downgraded to Equal Weight from Overweight at Wells Fargo
04/19/22 Truist
Moog Inc downgraded to Hold from Buy at Truist
02/23/22 Wells Fargo
Agilent price target lowered to $160 from $180 at Wells Fargo
A Agilent
$124.71 /

-1.33 (-1.06%)

A Agilent
$124.71 /

-1.33 (-1.06%)

A Agilent
$124.71 /

-1.33 (-1.06%)

On The Fly
Fly Intel: After-Hours Movers » 18:22
05/24/22
05/24
18:22
05/24/22
18:22
CAL

Caleres

$20.88 /

-1.51 (-6.74%)

, JWN

Nordstrom

$20.68 /

-0.77 (-3.59%)

, DDS

Dillard's

$235.40 /

-13.25 (-5.33%)

, M

Macy's

$17.62 /

-0.75 (-4.08%)

, VNET

VNET Group

$4.61 /

-0.87 (-15.89%)

, TOL

Toll Brothers

$44.42 /

-2.35 (-5.02%)

, URBN

Urban Outfitters

$18.00 /

-1.54 (-7.88%)

, INTU

Intuit

$358.78 /

-12.425 (-3.35%)

, A

Agilent

$124.71 /

-1.33 (-1.06%)

, WEN

Wendy's

$16.27 /

-0.4 (-2.40%)

, AHCO

AdaptHealth

$17.35 /

-0.235 (-1.34%)

, LYFT

Lyft

$16.72 /

-3.515 (-17.37%)

, IDCC

InterDigital

$60.79 /

+0.35 (+0.58%)

, KDNY

Chinook Therapeutics

$15.10 /

+0.335 (+2.27%)

Check out this evening's…

ShowHide Related Items >><<
WEN Wendy's
$16.27 /

-0.4 (-2.40%)

VNET VNET Group
$4.61 /

-0.87 (-15.89%)

URBN Urban Outfitters
$18.00 /

-1.54 (-7.88%)

TOL Toll Brothers
$44.42 /

-2.35 (-5.02%)

M Macy's
$17.62 /

-0.75 (-4.08%)

LYFT Lyft
$16.72 /

-3.515 (-17.37%)

KDNY Chinook Therapeutics
$15.10 /

+0.335 (+2.27%)

JWN Nordstrom
$20.68 /

-0.77 (-3.59%)

INTU Intuit
$358.78 /

-12.425 (-3.35%)

IDCC InterDigital
$60.79 /

+0.35 (+0.58%)

DDS Dillard's
$235.40 /

-13.25 (-5.33%)

CAL Caleres
$20.88 /

-1.51 (-6.74%)

AHCO AdaptHealth
$17.35 /

-0.235 (-1.34%)

A Agilent
$124.71 /

-1.33 (-1.06%)

CAL Caleres
$20.88 /

-1.51 (-6.74%)

01/11/22 Loop Capital
Loop Capital upgrades Steven Madden to Buy after positive news from peers
11/19/21 Loop Capital
Caleres price target raised to $40 from $35 at Loop Capital
09/07/21 Loop Capital
Caleres price target raised to $35 from $30 at Loop Capital
06/01/21 Loop Capital
Caleres price target raised to $30 from $25 at Loop Capital
JWN Nordstrom
$20.68 /

-0.77 (-3.59%)

05/16/22 JPMorgan
Nordstrom price target lowered to $22 from $24 at JPMorgan
03/02/22 BMO Capital
Nordstrom price target raised to $30 from $23 at BMO Capital
03/02/22 Deutsche Bank
Nordstrom price target raised to $31 from $22 at Deutsche Bank
03/02/22 Citi
Nordstrom price target raised to $27 from $25 at Citi
DDS Dillard's
$235.40 /

-13.25 (-5.33%)

05/16/22 JPMorgan
Dillard's price target raised to $185 from $160 at JPMorgan
11/30/21 UBS
Dillard's initiated with a Sell at UBS
M Macy's
$17.62 /

-0.75 (-4.08%)

05/16/22 JPMorgan
Macy's price target lowered to $30 from $33 at JPMorgan
05/11/22 OTR Global
Macy's view downgraded to Mixed from Positive at OTR Global
02/24/22 Citi
Citi upgrades Macy's to Neutral with challenges priced in
02/24/22 Citi
Macy's upgraded to Neutral from Sell at Citi
VNET VNET Group
$4.61 /

-0.87 (-15.89%)

05/16/22 Credit Suisse
VNET Group price target lowered to $8.20 from $10.80 at Credit Suisse
04/22/22 Jefferies
Selloff in China IDC stocks 'significantly overdone,' says Jefferies
11/22/21 HSBC
VNET Group upgraded to Buy from Hold at HSBC
11/19/21 Jefferies
Jefferies keeps Buy rating on VNET Group, says market concerns 'misplaced'
TOL Toll Brothers
$44.42 /

-2.35 (-5.02%)

04/13/22 JPMorgan
Toll Brothers price target lowered to $51 from $58 at JPMorgan
04/05/22 Credit Suisse
Toll Brothers initiated with an Outperform at Credit Suisse
03/31/22 Barclays
Toll Brothers price target lowered to $47 from $61 at Barclays
03/25/22 Citi
Toll Brothers price target lowered to $52 from $62 at Citi
URBN Urban Outfitters
$18.00 /

-1.54 (-7.88%)

05/23/22 Citi
Urban Outfitters price target lowered to $30 from $42 at Citi
05/17/22 B. Riley
Urban Outfitters price target lowered to $39 from $44 at B. Riley
05/16/22 JPMorgan
Urban Outfitters price target lowered to $26 from $32 at JPMorgan
04/05/22 Wells Fargo
Urban Outfitters price target lowered to $28 from $34 at Wells Fargo
INTU Intuit
$358.78 /

-12.425 (-3.35%)

05/20/22 Barclays
Intuit price target lowered to $480 from $585 at Barclays
05/02/22 BMO Capital
Intuit price target lowered to $550 from $600 at BMO Capital
04/25/22 Wells Fargo
Intuit price target lowered to $635 from $725 at Wells Fargo
03/21/22 BMO Capital
Indicators suggest 'slow forming tax season' for Intuit, says BMO Capital
A Agilent
$124.71 /

-1.33 (-1.06%)

05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
04/25/22 Wells Fargo
Agilent downgraded to Equal Weight from Overweight at Wells Fargo
04/19/22 Truist
Moog Inc downgraded to Hold from Buy at Truist
02/23/22 Wells Fargo
Agilent price target lowered to $160 from $180 at Wells Fargo
WEN Wendy's
$16.27 /

-0.4 (-2.40%)

05/12/22 Truist
Wendy's price target lowered to $27 from $29 at Truist
05/12/22 Wedbush
Wendy's price target lowered to $23 from $28.50 at Wedbush
05/12/22 Deutsche Bank
Wendy's price target lowered to $20 from $26 at Deutsche Bank
05/12/22 Barclays
Wendy's price target lowered to $25 from $28 at Barclays
AHCO AdaptHealth
$17.35 /

-0.235 (-1.34%)

05/12/22 Canaccord
AdaptHealth price target lowered to $26 from $29 at Canaccord
05/11/22 Deutsche Bank
AdaptHealth price target lowered to $22 from $28 at Deutsche Bank
03/08/22 RBC Capital
AdaptHealth price target lowered to $26 from $31 at RBC Capital
02/25/22 Canaccord
AdaptHealth price target lowered to $29 from $44 at Canaccord
LYFT Lyft
$16.72 /

-3.515 (-17.37%)

05/23/22 Bernstein
Lyft assumed with a Market Perform at Bernstein
05/16/22 Argus
Lyft price target lowered to $41 from $72 at Argus
05/05/22 DA Davidson
Lyft price target lowered to $27 from $60 at DA Davidson
05/05/22 MKM Partners
Uber price target lowered to $41 from $65 at MKM Partners
IDCC InterDigital
$60.79 /

+0.35 (+0.58%)

08/03/21 Roth Capital
Court ruling sets tone for unlicensed Chinese OEMs in Europe, says Roth Capital
KDNY Chinook Therapeutics
$15.10 /

+0.335 (+2.27%)

02/01/22 H.C. Wainwright
H.C. Wainwright sees no negative read-through from Chinook CMO departure
WEN Wendy's
$16.27 /

-0.4 (-2.40%)

VNET VNET Group
$4.61 /

-0.87 (-15.89%)

URBN Urban Outfitters
$18.00 /

-1.54 (-7.88%)

TOL Toll Brothers
$44.42 /

-2.35 (-5.02%)

M Macy's
$17.62 /

-0.75 (-4.08%)

LYFT Lyft
$16.72 /

-3.515 (-17.37%)

KDNY Chinook Therapeutics
$15.10 /

+0.335 (+2.27%)

JWN Nordstrom
$20.68 /

-0.77 (-3.59%)

INTU Intuit
$358.78 /

-12.425 (-3.35%)

IDCC InterDigital
$60.79 /

+0.35 (+0.58%)

DDS Dillard's
$235.40 /

-13.25 (-5.33%)

CAL Caleres
$20.88 /

-1.51 (-6.74%)

AHCO AdaptHealth
$17.35 /

-0.235 (-1.34%)

A Agilent
$124.71 /

-1.33 (-1.06%)

  • 25
    May
  • 30
    Nov
  • 10
    Nov
WEN Wendy's
$16.27 /

-0.4 (-2.40%)

TOL Toll Brothers
$44.42 /

-2.35 (-5.02%)

M Macy's
$17.62 /

-0.75 (-4.08%)

LYFT Lyft
$16.72 /

-3.515 (-17.37%)

JWN Nordstrom
$20.68 /

-0.77 (-3.59%)

INTU Intuit
$358.78 /

-12.425 (-3.35%)

WEN Wendy's
$16.27 /

-0.4 (-2.40%)

VNET VNET Group
$4.61 /

-0.87 (-15.89%)

URBN Urban Outfitters
$18.00 /

-1.54 (-7.88%)

TOL Toll Brothers
$44.42 /

-2.35 (-5.02%)

M Macy's
$17.62 /

-0.75 (-4.08%)

LYFT Lyft
$16.72 /

-3.515 (-17.37%)

JWN Nordstrom
$20.68 /

-0.77 (-3.59%)

INTU Intuit
$358.78 /

-12.425 (-3.35%)

DDS Dillard's
$235.40 /

-13.25 (-5.33%)

CAL Caleres
$20.88 /

-1.51 (-6.74%)

AHCO AdaptHealth
$17.35 /

-0.235 (-1.34%)

A Agilent
$124.71 /

-1.33 (-1.06%)

VNET VNET Group
$4.61 /

-0.87 (-15.89%)

URBN Urban Outfitters
$18.00 /

-1.54 (-7.88%)

TOL Toll Brothers
$44.42 /

-2.35 (-5.02%)

M Macy's
$17.62 /

-0.75 (-4.08%)

LYFT Lyft
$16.72 /

-3.515 (-17.37%)

JWN Nordstrom
$20.68 /

-0.77 (-3.59%)

INTU Intuit
$358.78 /

-12.425 (-3.35%)

CAL Caleres
$20.88 /

-1.51 (-6.74%)

A Agilent
$124.71 /

-1.33 (-1.06%)

Earnings
Agilent raises FY22 EPS view to $4.86-$4.93, consensus $4.60 » 16:09
05/24/22
05/24
16:09
05/24/22
16:09
A

Agilent

$124.11 /

-1.93 (-1.53%)

Prior guidance was…

Prior guidance was $4.80-$4.90. Backs FY22 revenue view of $6.67B-$6.73B, consensus $6.36B.

ShowHide Related Items >><<
A Agilent
$124.11 /

-1.93 (-1.53%)

A Agilent
$124.11 /

-1.93 (-1.53%)

05/16/22 Citi
Citi opens 'positive catalyst watch' on Agilent into earnings
04/25/22 Wells Fargo
Agilent downgraded to Equal Weight from Overweight at Wells Fargo
04/19/22 Truist
Moog Inc downgraded to Hold from Buy at Truist
02/23/22 Wells Fargo
Agilent price target lowered to $160 from $180 at Wells Fargo
A Agilent
$124.11 /

-1.93 (-1.53%)

A Agilent
$124.11 /

-1.93 (-1.53%)

A Agilent
$124.11 /

-1.93 (-1.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.